This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Read More

Aspergillosis Treatment Market

Aspergillosis Treatment Market

Aspergillosis Treatment Market

Aspergillosis Treatment Market:Global Industry Analysis 2015 - 2019 and Opportunity Assessment; 2020 - 2030

Aspergillosis Treatment Market Overview

COVID-19 IMAPCT ON THE ASPERGILLOSIS TREATMENT MARKET

Aspergillosis is an infection or allergic reaction caused by various kinds of molds found on plants, soil, building materials or rotting vegetables. Aspergillosis treatment is expected to witness lucrative growth due to the increasing prevalence of different types of aspergillosis diseases over the years.

Based on type, the global aspergillosis treatment market is divided into allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis, aspergilloma, chronic pulmonary aspergillosis, invasive aspergillosis and cutaneous (skin) aspergilllosis.

Among these, ABPA is observed as one of the most common aspergillosis in which inflammation in the lungs and allergy symptoms such as coughing and wheezing are observed.

Invasive aspergillosis is the most severe type is apergillosis as the infection travels from the lungs to bloodstream infecting other organs of the body such as kidney, brain, liver or skin. It is mostly observed in people with low immunity.

The breakout of COVID-19 has led an impact on the global aspergillosis treatment market. The worldwide lockdowns may have result in slowing down the sales of the market in the current situation.

However, the global aspergillosis treatment market is estimated to pick up the pace and could grow substantially in the forecast years.

Aspergillosis Treatment Market: Drivers and Restraints

The increasing prevalence of aspergillosis around the world is expected to drive the growth of the aspergillosis treatment market. Favorable government frameworks are also expected to contribute significant growth towards the growth of aspergillosis treatment market.However, patent expiration of branded therapeutics is expected to restrict the growth of aspergillosis treatment market.

Aspergillosis Treatment Market: Overview

The global market for aspergillosis treatment market is estimated to experience a significant growth during the forecast period due to increasing prevalence of aspergillosis.

Based on type, the global aspergillosis treatment market is divided into allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis, aspergilloma, chronic pulmonary aspergillosis, invasive aspergillosis and cutaneous (skin) aspergilllosis.

Among these, the ABPA is the most type of aspergillosis. Thus, it is expected to generate highest revenue in the forecast period.On the basis of drug class, the global aspergillosis treatment market is segmented into corticosteroids and anti-fungal drugs.

The corticosteroids that are highly preferred are prednisone, prednisolone and methylprednisolone. Antifungals are further classified into voriconazole, itraconazole, caspofungin, micafungin, amphotericin B and isavuconazole. Antifungals such as voriconazole and isavuconazole are expected to be the leading drivers of the global aspergillosis treatment market in the forecast period.

On the basis of distribution channels, the global aspergillosis market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

Aspergillosis Treatment Market: Regional-Wise Outlook

Geographically, the aspergillosis treatment market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa.

The North America is expected to dominate the global aspergillosis treatment market due to increasing government initiatives for diagnosing and treatment of infections. Europe is expected to have the second largest market for global aspergillosis treatment market due to increasing increasing prevalence of the disease.

Additionally, East Asia is expected to observe a substantial growth in the aspergillosis treatment market. However, South Asia is anticipated to experience fastest growth in the aspergillosis treatment market, owing to large volume of untreated patients.

 Developing medical infrastructure and increasing awareness of infectious diseases may lead to steady growth in Latin America. In the Middle East and Africa the market growth is expected to be limited due to slow economic growth, underdeveloped infrastructure and lower access to technological advancement.

Aspergillosis Treatment Market: Key players

Some of the players identified in the aspergillosis treatment market include:

  • Pfizer Inc.
  • Astra Zeneca plc.
  • Merck and co.
  • GlaxoSmithKline
  • Mylan Pharmaceuticals
  • Novartis AG
  • Abbott Laboratories
  • Takeda Pharmaceutical Company ltd.
  • Basilea pharmaceutica ltd.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Regional analysis of the aspergillosis treatment market report includes

  • North America
  • Latin America
  • Europe
  • South  Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Aspergillosis Treatment Market Report Highlights:

  • Overview of Global Healthcare Market
  • Evolution of the technology
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Aspergillosis Treatment Market: Segmentation

Tentatively, the global aspergillosis treatment market has been segmented on the basis of type, drug class and distribution channel.

By Type:

  • Allergic Bronchopulmonary Aspergellosis
  • Allergic Aspergillus Sinusitis
  • Aspergilloma
  • Chronic Pulmonary Aspergillosis
  • Invasive Aspergillosis
  • Cutaneous (skin) Aspergillosis

By drug class:

  • Anti-fungal
  • Voriconazole
  • Itraconazole
  • Caspofungin
  • Micafungin
  • Amphotericin B
  • Isavuconazole
  • Corticosteroids
  • Prednisolone
  • Prednisone
  • Methylprednisolone

By distribution channel:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

Need specific information?

Our Clients

Healthcare

View All Reports from Healthcare

View Reports

Recommendations

Healthcare

Insulin Pens Market

Published : 2021-07-16

Healthcare

Americas Covid 19 Testing Market

Published : 2021-07-23

Healthcare

Nasal Antihistamines Market

Published : 2021-10-18

Healthcare

Wet Wipes Market

Published : 2021-08-26